000			01921nas a22003015i 4500
001			1776-260X
003			DE-He213
005			20260610082527.0
007			cr nn 008mamaa
008			150723s||||||||sz uu poo|||||| b|EN |d
022			_a1776-260X
024	7		_a10.1007/11523.1776-260X _2doi
210	1	0	_aTarg Oncol
245	1	0	_aTargeted Oncology _h[electronic resource] / _cedited by Martin Chopra.
264		1	_aCham : _bSpringer International Publishing : _bImprint: Adis.
300			_bonline resource.
520			_aTargeted Oncology addresses physicians and scientists committed to oncology and cancer research by providing a programme of articles on molecularly targeted pharmacotherapy in oncology. The journal includes: Original Research Articles on all aspects of molecularly targeted agents for the treatment of cancer, including immune checkpoint inhibitors and related approaches. Comprehensive narrative Review Articles and shorter Leading Articles discussing relevant clinically established as well as emerging agents and pathways. Current Opinion articles that place interesting areas in perspective. Therapy in Practice articles that provide a guide to the optimum management of a condition and highlight practical, clinically relevant considerations and recommendations. Systematic Reviews that use explicit, systematic methods as outlined by the PRISMA statement. Adis Drug Reviews of the properties and place in therapy of both newer and established targeted drugs in oncology.
650		0	_aOncology.
650		0	_aMedicine—Research.
650		0	_aBiology—Research.
650	1	4	_aOncology.
650	2	4	_aBiomedical Research.
700	1		_aChopra, Martin. _eeditor. _4edt _4http://id.loc.gov/vocabulary/relators/edt
710	2		_aSpringerLink (Online service)
776	0	8	_iPrinted version: _x1776-2596
856	4	0	_uhttps://doi.org/10.1007/11523.1776-260X _zHybrid
999			_c4010 _d4010